Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
On track to submit planned special 510(k) for Pure-Vu Gen 4 Gastro and Colon to the FDA in Q4 2023;Received system wide approval in the Banner Med...
Source: businessinsider.com